Health Canada records a seller-labelled 10 mg tesamorelin product among unauthorized health products seized from a Canadian business.
Each answer stays attached to the compound identity and destination records. This is a verification guide, not medical or legal advice, a seller recommendation, or proof of availability.
Health Canada records a seller-labelled 10 mg tesamorelin product among unauthorized health products seized from a Canadian business. That record does not establish the status or identity of every tesamorelin listing, and it does not transfer the US EGRIFTA WR approval to a research vial.
Resolve the exact identity of Tesamorelin through Check the FDA Purple Book product record from U.S. Food and Drug Administration. Then search Drug Product Database from Health Canada for the destination product record and Choosing a safe online pharmacy from Health Canada for the seller, establishment, or supply route in Canada. A match in one record does not replace the other two checks.
No. A page using the name Tesamorelin, local currency, a domestic delivery claim, or a familiar package image is only a lead. This record resolves seller-labelled 10 mg tesamorelin research listings. EGRIFTA WR is a separate FDA-licensed prescription product with a specific application, 11.6 mg presentation, indication, label, and regulated supply chain. The research listings do not inherit that approval. For Canada, the exact product, presentation, seller identity, current record status, and claimed supply route must resolve through the official sources on this page.
Health Canada records a seller-labelled 10 mg tesamorelin product among unauthorized health products seized from a Canadian business. That record does not establish the status or identity of every tesamorelin listing, and it does not transfer the US EGRIFTA WR approval to a research vial.
Primary identity source: Check the FDA Purple Book product record / U.S. Food and Drug Administration ↗A credible result must keep these separate. The official links answer different questions and should be checked in sequence.
Check the FDA Purple Book product record is maintained by U.S. Food and Drug Administration. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.
Open Check the FDA Purple Book product record ↗Drug Product Database is maintained by Health Canada. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.
Open Drug Product Database ↗Choosing a safe online pharmacy is maintained by Health Canada. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.
Open Choosing a safe online pharmacy ↗Health Canada warned in April 2026 that unauthorized injectable peptide drugs sold online can cause serious harm and said products labelled for research use should not be used as drugs.
The country guide supplies the local verification sequence. It does not convert an online listing into an authorized product or verified seller.
Authorized drugs sold in Canada carry an eight-digit Drug Identification Number that can be checked in Health Canada’s database.
Use the pharmacy regulatory authority for the province or territory where the business is established, including for online sellers.
Do not treat a ‘research use only’ label, imported parcel, or wellness claim as a prescription or authorization pathway.
Open the live record and confirm its current status. A linked source begins the verification process; it does not mean Peptide Local authenticated a product or seller.